rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Paul A. Grayson

Director

Company insider

Files Form 4 as: Director, Skye Bioscience.

Every Form 4 they filed

In numbers

Trades disclosed
12
Buys
0
Sells
2
Bought
$0
Sold
$432K
Companies
1
Companies where not an officer
1
First trade
25 Aug 2023
Last trade
31 Mar 2026
Last filed
2 Apr 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
SKYE Skye BioscienceDirector · Biotechnology · last 31 Mar 20260 buys · 2 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
20Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
31 Mar 2026filed 2 Apr 2026SKYE Skye Bioscienceoption or derivative · BiotechnologySEC FORM 4 Code A—75,000 at $0.00filing
31 Mar 2026filed 2 Apr 2026SKYE Skye Bioscienceoption or derivative · BiotechnologySEC FORM 4 Code A—75,000 at $0.00filing
6 Feb 2026filed 9 Feb 2026SKYE Skye Bioscienceoption or derivative · BiotechnologySEC FORM 4 Code A—35,000 at $0.00filing
6 Feb 2026filed 9 Feb 2026SKYE Skye Bioscienceoption or derivative · BiotechnologySEC FORM 4 Code A—35,000 at $0.00filing
24 Feb 2025filed 26 Feb 2025SKYE Skye Bioscienceoption or derivative · BiotechnologySEC FORM 4 Code A—135,000 at $0.00filing
18 Nov 2024filed 19 Nov 2024SKYE Skye BioscienceBiotechnologySEC FORM 4 Sold$430K86,244 at $4.99filing
15 Nov 2024filed 19 Nov 2024SKYE Skye BioscienceBiotechnologySEC FORM 4 Sold$1,704307 at $5.55filing
28 Oct 2024filed 30 Oct 2024SKYE Skye Bioscienceoption or derivative · BiotechnologySEC FORM 4 Code A—70,000 at $0.00filing
29 Feb 2024filed 4 Mar 2024SKYE Skye Bioscienceoption or derivative · BiotechnologySEC FORM 4 Code A—35,000 at $0.00filing
29 Feb 2024filed 4 Mar 2024SKYE Skye BioscienceBiotechnologySEC FORM 4 Code A—100,000 at $0.00filing
6 Nov 2023filed 6 Nov 2023SKYE Skye BioscienceBiotechnologySEC FORM 4 Code A—173,721 at $0.00filing
25 Aug 2023filed 29 Aug 2023SKYE Skye BioscienceBiotechnologySEC FORM 4 Code A—18,132,596filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care2

Buys in green, sells in red, by the company’s sector.

Related people

Andrew J. SchwabDirector and 10% owner · Director and 10% owner at Skye Bioscience, filing Form 4 there in the last year
5AM Partners VII, LLC10% owner · 10% owner at Skye Bioscience, filing Form 4 there in the last year
Kush ParmarDirector · 10% owner at Skye Bioscience, filing Form 4 there in the last year
Punit DhillonChief Executive Officer · Chief Executive Officer at Skye Bioscience, filing Form 4 there in the last year
Christopher TwittyChief Scientific Officer · Chief Scientific Officer at Skye Bioscience, filing Form 4 there in the last year